Cargando…

Brain atrophy measurement over a MRI scanner change in multiple sclerosis

BACKGROUND: A change in MRI hardware impacts brain volume measurements. The aim of this study was to use MRI data from multiple sclerosis (MS) patients and healthy control subjects (HCs) to statistically model how to adjust brain atrophy measures in MS patients after a major scanner upgrade. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sinnecker, Tim, Schädelin, Sabine, Benkert, Pascal, Ruberte, Esther, Amann, Michael, Lieb, Johanna M., Naegelin, Yvonne, Müller, Jannis, Kuhle, Jens, Derfuss, Tobias, Kappos, Ludwig, Wuerfel, Jens, Granziera, Cristina, Yaldizli, Özgür
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9424626/ https://www.ncbi.nlm.nih.gov/pubmed/36007437 http://dx.doi.org/10.1016/j.nicl.2022.103148

Ejemplares similares

Comparative analysis of dimethyl fumarate and fingolimod in relapsing–remitting multiple sclerosis
por: Lorscheider, Johannes, et al.
Publicado: (2020)

Evaluation of frequency, severity, and independent risk factors for recurrence of disease activity after fingolimod discontinuation in a large real-world cohort of patients with multiple sclerosis
por: Cerdá-Fuertes, Nuria, et al.
Publicado: (2023)

Classification of multiple sclerosis based on patterns of CNS regional atrophy covariance
por: Tsagkas, Charidimos, et al.
Publicado: (2021)

Central nervous system atrophy predicts future dynamics of disability progression in a real‐world multiple sclerosis cohort
por: Tsagkas, Charidimos, et al.
Publicado: (2021)

Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis
por: Disanto, Giulio, et al.
Publicado: (2017)

Improving Accuracy of Brainstem MRI Volumetry: Effects of Age and Sex, and Normalization Strategies
por: Sander, Laura, et al.
Publicado: (2020)

Intrathecal Immunoglobulin M Synthesis is an Independent Biomarker for Higher Disease Activity and Severity in Multiple Sclerosis
por: Oechtering, Johanna, et al.
Publicado: (2021)

Choroid Plexus Volume in Multiple Sclerosis vs Neuromyelitis Optica Spectrum Disorder: A Retrospective, Cross-sectional Analysis
por: Müller, Jannis, et al.
Publicado: (2022)

Fingolimod in children with Rett syndrome: the FINGORETT study
por: Naegelin, Yvonne, et al.
Publicado: (2021)

Regional Cerebellar Volume Loss Predicts Future Disability in Multiple Sclerosis Patients
por: Parmar, Katrin, et al.
Publicado: (2021)

Association of Brain Atrophy With Disease Progression Independent of Relapse Activity in Patients With Relapsing Multiple Sclerosis
por: Cagol, Alessandro, et al.
Publicado: (2022)

Untangling normal aging from disease-related brain atrophy in MS
por: Sinnecker, Tim, et al.
Publicado: (2019)

Longitudinal changes of deep gray matter shape in multiple sclerosis
por: Tsagkas, Charidimos, et al.
Publicado: (2022)

Optical coherence tomography versus other biomarkers: Associations with physical and cognitive disability in multiple sclerosis
por: Cerdá-Fuertes, Nuria, et al.
Publicado: (2023)

Personalized maps of T1 relaxometry abnormalities provide correlates of disability in multiple sclerosis patients
por: Chen, Xinjie, et al.
Publicado: (2023)

Measuring and Validating the Levels of Brain-Derived Neurotrophic Factor in Human Serum
por: Naegelin, Yvonne, et al.
Publicado: (2018)

Severe exacerbation of relapsing-remitting multiple sclerosis after G-CSF therapy
por: Rust, Heiko, et al.
Publicado: (2016)

Growth differentiation factor 15 is increased in stable MS
por: Amstad, Andrea, et al.
Publicado: (2020)

Combination of teriflunomide and interferon as follow-up therapy after fingolimod-associated PML
por: Fischer-Barnicol, Bettina, et al.
Publicado: (2020)

Longitudinal patterns of cortical thinning in multiple sclerosis
por: Tsagkas, Charidimos, et al.
Publicado: (2020)

Optical coherence tomography reflects clinically relevant gray matter damage in patients with multiple sclerosis
por: Cagol, Alessandro, et al.
Publicado: (2023)

Death Anxiety and Attitudes towards Death in Patients with Multiple Sclerosis: An Exploratory Study
por: Francalancia, Jara, et al.
Publicado: (2021)

Immunological Predictors of Dimethyl Fumarate‐Induced Lymphopenia
por: Diebold, Martin, et al.
Publicado: (2022)

Serum neurofilament light chain is a useful biomarker in pediatric multiple sclerosis
por: Reinert, Marie-Christine, et al.
Publicado: (2020)

Intrathecal IgM Synthesis Is Associated with Spinal Cord Manifestation and Neuronal Injury in Early MS
por: Oechtering, Johanna, et al.
Publicado: (2022)

Monitoring of radiologic disease activity by serum neurofilaments in MS
por: Uher, Tomas, et al.
Publicado: (2020)

Biomarkers of treatment response in patients with progressive multiple sclerosis treated with high‐dose pharmaceutical‐grade biotin (MD1003)
por: Collongues, Nicolas, et al.
Publicado: (2020)

Cerebellar Abnormalities Contribute to Disability Including Cognitive Impairment in Multiple Sclerosis
por: Weier, Katrin, et al.
Publicado: (2014)

Hepatitis E virus infections in patients with MS on oral disease-modifying treatment
por: Diebold, Martin, et al.
Publicado: (2019)

High-dimensional immune profiling identifies a biomarker to monitor dimethyl fumarate response in multiple sclerosis
por: Diebold, Martin, et al.
Publicado: (2022)

Quantitative 7T MRI does not detect occult brain damage in neuromyelitis optica
por: Pasquier, Baptiste, et al.
Publicado: (2019)

Chronic White Matter Inflammation and Serum Neurofilament Levels in Multiple Sclerosis
por: Maggi, Pietro, et al.
Publicado: (2021)

Microstructure-Weighted Connectomics in Multiple Sclerosis
por: Bosticardo, Sara, et al.
Publicado: (2022)

Unraveling Natalizumab Effects on Deregulated miR-17 Expression in CD4(+) T Cells of Patients with Relapsing-Remitting Multiple Sclerosis
por: Meira, Maria, et al.
Publicado: (2014)

Individual Assessment of Brain Tissue Changes in MS and the Effect of Focal Lesions on Short-Term Focal Atrophy Development in MS: A Voxel-Guided Morphometry Study
por: Fox, Jan, et al.
Publicado: (2016)

Efficacy and Safety of Fingolimod in an Unselected Patient Population
por: Rasenack, Maria, et al.
Publicado: (2016)

The Swiss Multiple Sclerosis Cohort-Study (SMSC): A Prospective Swiss Wide Investigation of Key Phases in Disease Evolution and New Treatment Options
por: Disanto, Giulio, et al.
Publicado: (2016)

PARP-1 deregulation in multiple sclerosis
por: Meira, Maria, et al.
Publicado: (2019)

Development, validation and clinical usefulness of a prognostic model for relapse in relapsing-remitting multiple sclerosis
por: Chalkou, Konstantina, et al.
Publicado: (2021)

Receptor clustering and pathogenic complement activation in myasthenia gravis depend on synergy between antibodies with multiple subunit specificities
por: Rose, Natalie, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3ve0i4it813459evbjm8c1j5bf